Skip to main content
. 2021 Apr 1;17(4):739–748. doi: 10.5664/jcsm.9032

Table 2.

Sleep laboratory results between groups.

S+N+C (n = 11): Group A N+C (n = 11): Group B S (n = 11): Group C Normal (n = 11): Group D P Post Hoc P
PSG
AHI (events/h) 6.08 ± 7.97 3.26 ± 4.95 5.78 ± 9.27 1.57 ± 1.50 .455
Efficiency (%) 77.35 ± 10.91 82.53 ± 11.87 79.93 ± 10.12 86.93 ± 14.24 .104
Awake (%) 17.25 ± 11.62 16.05 ± 11.14 14.87 ± 12.75 9.18 ± 12.38 .100
REM (%) 25.82 ± 9.34 17.80 ± 6.12 16.83 ± 7.90 15.39 ± 5.78 .044* A/B: .014, A/C: .034, A/D: .022
Stage 1 (%) 17.60 ± 8.29 16.58 ± 8.22 23.11 ± 23.79 10.10 ± 6.64 .171
Stage 2 (%) 34.33 ± 12.24 37.10 ± 9.29 49.38 ± 15.52 45.88 ± 8.20 .009* A/D: .034, B/C: .017, B/D: .017
SWS (%) 17.86 ± 10.31 21.90 ± 9.64 10.57 ± 17.03 19.66 ± 6.54 .036* A/C: .041, B/C: .008, C/D: .050
TST (min) 352.95 ± 40.13 390.42 ± 53.48 395.13 ± 57.73 363.49 ± 58.37 .141
PLMI 5.81 ± 8.92 4.01 ± 13.39 0.00 ± 0.00 0.65 ± 1.71 .044* A/B: .045, A/C: .017, C/D:.037
Mean SaO2 (%) 96.81 ± 1.25 96.84 ± 1.05 94.75 ± 2.38 97.08 ± 0.78 .037* A/C: .040, B/C: .006, C/D: .013
MSLT
Mean sleep latency (min) 3.35 ± 3.23 3.00 ± 2.36 13.33 ± 5.51 13.33 ± 4.09 .000* A/C: .002, A/D: .001, B/C: .000, B/D: .000
Number of sleep latency < 5 min 3.40 ± 1.96 4.31 ± 0.84 1.13 ± 1.48 1.00 ± 1.22 .000* A/C: .018, A/D: .011, B/C: .000, B/D: .000
SOREM 3.40 ± 1.43 3.94 ± 1.16 0.25 ± 0.70 0.11 ± 0.33 .000* A/C: .001, A/D: .001, B/C: .000, B/D:.000

*P < .05. Group A, S+N+C: schizophrenia and narcolepsy type 1, the dual diagnoses group; group B, N+C, narcolepsy type 1, the narcolepsy group; group C, S: schizophrenia, the schizophrenia group; group D, normal: healthy control, the healthy control group. AHI = apnea-hypopnea index, mean SaO2 = mean oxygen saturation, MSLT = multiple sleep latency test, PLMI = periodic limb movement index, PSG = polysomnography, REM = rapid eye movement period, SOREM = sleep-onset REM periods, SWS = slow wave sleep, TST = total sleep time.